A Randomized Placebo-Controlled Safety and Pharmacodynamic Study of KB002, a Chimeric Anti-GM-CSF Monoclonal Antibody, in Patients with AsthmaNéstor A. Molfino, Geoffrey Yarranton, Philip G. Bardin et al.|Journal of Allergy and Clinical Immunology|2013Cited by 3